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ABSTRACT R-Ras2/TC21 is a GTPase with high sequence and signaling similarity with Ras 
subfamily members. Although it has been extensively studied using overexpression studies in 
cell lines, its physiological role remains poorly characterized. Here we used RRas2-knockout 
mice expressing β-galactosidase under the regulation of the endogenous RRas2 promoter to 
investigate the function of this GTPase in vivo. Despite its expression in tissues critical for 
organismal viability, RRas2−/− mice show no major alterations in viability, growth rates, cardio-
vascular parameters, or fertility. By contrast, they display a marked and specific defect in the 
development of the mammary gland during puberty. In the absence of R-Ras2/TC21, this 
gland forms reduced numbers of terminal end buds (TEBs) and ductal branches, leading to a 
temporal delay in the extension and arborization of the gland tree in mammary fat pads. This 
phenotype is linked to cell-autonomous proliferative defects of epithelial cells present in 
TEBs. These cells also show reduced Erk activation but wild type–like levels of phosphorylat-
ed Akt. Using compound RRas2-, HRas-, and NRas-knockout mice, we demonstrate that these 
GTPases act in a nonsynergistic and nonadditive manner during this morphogenic process.
INTRODUCTION
R-Ras2/TC21 is a member of the Ras GTPase superfamily that was 
originally isolated during the PCR-mediated screening of Ras-
related GTPases in a teratocarcinoma cell line (Drivas et al., 1990) 
and, some years later, during expression cloning approaches 
aimed at identifying human oncogenes present in ovarian tumors 
(Chan et al., 1994). By homology criteria, R-Ras2/TC21 belongs to 
the R-Ras subfamily, which includes two additional GTPases: 
R-Ras/R-Ras1 and R-Ras3/M-Ras (Colicelli, 2004). Within this sub-
family, R-Ras2/TC21 is the GTPase that shows more structural simi-
larity to the classic H-Ras, K-Ras, and N-Ras proteins (Drivas et al., 
1990; Colicelli, 2004).
R-Ras2/TC21 was the focus of attention some years ago be-
cause, unlike the other R-Ras and Rap proteins, it displayed trans-
forming activities similar to those exhibited by the conventional Ras 
subfamily proteins (Chan et al., 1994; Graham et al., 1994, 1999; 
Movilla et al., 1999; Rosario et al., 1999, 2001). This observation, 
coupled with the fact that mutations in its gene were found in some 
cancer cell lines (Chan et al., 1994; Huang et al., 1995; Barker and 
Crompton, 1998), led to the idea that R-Ras2/TC21 could be an 
alternative route to promoting tumorigenesis in tumors that did not 
have a constitutive activation of classic Ras GTPases. Consistent 
with that hypothesis, a number of studies also revealed that the 
RRas2 gene and/or its encoded protein was overexpressed in some 
cancer cell lines and/or tumors (Clark et al., 1996; Arora et al., 2005; 
Rokavec et al., 2008; Macha et al., 2009; Luo et al., 2010; Lee et al., 
2011). However, we now know that the RRas2 gene is seldom 
mutated in human tumors (www.sanger.ac.uk/perl/genetics/CGP/
cosmic?action=gene&ln=RRAS2), indicating that it is unlikely that it 
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β-galactosidase–encoding retroviral construct downstream of the 
first exon of the RRas2 locus, can express β-galactosidase under 
the regulation of the endogenous RRas2 promoter when the 
mutant allele is in heterozygosis or homozygosis (Delgado 
et al., 2009). This property allows the detection of the expression 
of this gene using standard 5-bromo-4-chloro-3-indolyl β-d-
galactopyranoside (X-gal)–based staining techniques (Nagi et al., 
2003). Using this approach, we found that the expression pattern 
of RRas2 varies in complexity along embryonic development. 
Thus, using whole-mount embryos, we observed that the X-gal 
signals are specifically concentrated in the heart area at embryonic 
stages (E) 10.5 (Figure 1, A and B) and 11.5 (Figure 1, C and D). At 
E13.5, the expression pattern of R-Ras2/TC21 is more widespread, 
being detected in the heart, the spinal cord, and the finger precur-
sors of both the hindlimb and forelimb footpads (Figure 1, E and 
F). However, the expression in those new sites was very transient, 
since at E14.5 the expression was concentrated again in the heart 
area (Figure 1G). At E16.5, the staining of embryonic sections with 
X-gal revealed that the RRas2 gene was expressed in the heart 
(Figure 1, H, I, and M), tooth buds (Figure 1H), kidneys (Figure 1H), 
thymi (Figure 1, J and M), lungs (Figure 1, K and M), intestine 
(Figure 1, H, L, and N), aorta (Figure 1, H and M), pulmonary artery 
(Figure 1M), and bladder (Figure 1N). Confirming the specificity of 
the staining, no X-gal signals were observed in RRas2+/+ embryos 
(unpublished data).
To analyze the expression pattern of the RRas2 gene in postem-
bryonic stages, we first analyzed the expression levels of its tran-
script in a number of tissues obtained from 3-mo-old mice using 
quantitative reverse transcription PCR (qRT-PCR). We found expres-
sion of the gene in many of the tissues surveyed, although they 
show marked differences in terms of overall mRNA levels. Tissues 
with the highest expression of the RRas2 mRNA included the lung 
and testis (Figure 2A). Tissues with moderate expression levels in-
cluded different parts of the gut, the bladder, the white adipose 
tissue, the ovary, and, as expected (Delgado et al., 2009), he-
matopoietic tissues such as the thymus and spleen (Figure 2A). 
Other tissues, such as the heart, trachea, a number of glands (adre-
nal, salivary, mammary, bulbourethral), kidney, eyes, skin, and the 
brain, showed lower levels of expression (Figure 2A). Tissues with 
very low expression levels included the tongue, liver, skeletal mus-
cle, and brown adipose (Figure 2A).
To obtain more information about the expression pattern of the 
RRas2 gene at the single-cell level in the adult period, we per-
formed X-gal staining with selected tissues obtained from RRas2+/− 
mice. In the lung, we detected strong X-gal signals in smooth 
muscle cells and alveolar cells (Figure 2, B and C) and, to a lower 
extent, in a small percentage of cells present in the bronchial epi-
thelium (Figure 2C). In the testis, the expression of the RRas2 gene 
was restricted to Sertoli cells (Figure 2D), a group of cells with nur-
turing functions for developing sperm cells that are located in 
seminiferous tubules. In the ovary, X-gal staining was localized in 
the corpus luteum (Figure 2E), a structure involved in the secretion 
of pregnancy-related hormones, and in its surrounding stroma 
(unpublished data). In white adipose tissue, the expression of the 
RRas2 gene was found in adipocytes (Figure 2F). In the cardiovas-
cular system, we detected expression of RRas2 in cardiomyocytes 
(Figure 2G), arterial smooth muscle cells (Figure 2H), and vascular 
endothelial cells (Figure 2H). The tubules of the mammary gland 
displayed expression of R-Ras2/TC21 in the outer myoepithelial 
layer but not in the luminal layer of epithelial cells (Figure 2I). 
Finally, we detected strong X-gal staining in the smooth muscle 
cell and epithelial layers of both the duodenum (Figure 2J) and 
could represent an alternative way to activate Ras-dependent routes 
in tumors lacking Ras subfamily oncogenes.
Owing to its high transforming activity, the characterization of 
its signaling elements has been circumscribed so far to the use 
of active versions of the GTPase in cancer cell contexts. These stud-
ies have revealed that constitutively active R-Ras2/TC21 triggers 
critical biological processes for cancer cells, including proliferation 
(Graham et al., 1994, 1996, 1999; Movilla et al., 1999; Rosario et al., 
1999), migration (Keely et al., 1999; Huang et al., 2004; Luo et al., 
2010), epithelial–mesenchymal transition (Luo et al., 2010), and re-
sistance to both chemotherapy (Rong et al., 2002; Mendes-Pereira 
et al., 2012) and anoikis (McFall et al., 2001). In addition, it promotes 
the activation of a number of Ras-like signaling routes, such as those 
regulated by Raf1/MEK/Erk (Movilla et al., 1999; Rosario et al., 
1999), RalGDS/Ral (Lopez-Barahona et al., 1996; Rosario et al., 
2001), p38 mitogen-activated protein kinase (Graham et al., 1994), 
c-Jun N-terminal kinase (Graham et al., 1994; Movilla et al., 1999), 
protein kinase Cɛ (Murphy et al., 2002; Kelley et al., 2004), and phos-
phatidylinositol-3 kinase (PI3-K; McFall et al., 2001; Rosario et al., 
2001; Murphy et al., 2002; Rong et al., 2002). It should be noted, 
however, that other studies have argued against the involvement of 
Raf1-dependent (Graham et al., 1996, 1999; Light et al., 2002) and 
RalGDS-dependent (Murphy et al., 2002) routes in the transforma-
tion induced by R-Ras2/TC21. The reason for this discrepancy is un-
known. Additional studies have shown that wild-type R-Ras2/TC21 
shares the GDP/GTP exchange factors (GEFs; Graham et al., 1996; 
Movilla et al., 1999; Ohba et al., 2000; Calvo and Crespo, 2009) and 
GTPase-activating proteins (GAPs; Ohba et al., 2000) that catalyze 
the activation and deactivation steps of Ras proteins, respectively. 
R-Ras2/TC21 can be also targeted by Rap1-specific GEFs (i.e., C3G) 
and R-Ras1-specific GAPs (Ohba et al., 2000). These results suggest 
that R-Ras2/TC21 will be regulated during signal transduction by 
mechanisms and signals very similar to those used by cells to stimu-
late Ras subfamily GTPases.
In contrast to the wealth of information on the role of R-Ras2/
TC21 in cancer-related biological processes, very little is known 
about its physiological role in vivo. To address this issue, we re-
cently generated a strain of R-Ras2/TC21–deficient mice, using a 
retroviral insertion inactivation approach (Delgado et al., 2009). 
These mice display very low levels of RRas2 transcript and negli-
gible amounts of its encoded protein, thus allowing the analysis of 
the role of this GTPase in vivo (Delgado et al., 2009). The analysis 
of those mice showed that R-Ras2/TC21 is important for the en-
gagement of B-cell receptor tonic signals that, via the stimulation 
of PI3-Kδ, ensure the proper homeostasis of peripheral lympho-
cytes (Delgado et al., 2009). This GTPase is also critical for T-cell 
trogocytosis, a phagocyte-like mechanism that promotes the inter-
nalization of the T-cell receptor/antigen–major histocompatibility 
complex complexes from the immune synapse in a PI3-Kδ/RhoG–
dependent manner (Martinez-Martin et al., 2011). In the present 
work, we used this mouse strain to investigate the potential role of 
R-Ras2/TC21 in additional physiological and/or developmental 
roles in vivo. This led us to discover that this GTPase is important 
for the proper development and morphogenesis of the mammary 
gland during puberty.
RESULTS
RRas2 is expressed from early developmental 
stages to adulthood
We used the previously described strain of RRas2 knockout mice 
to investigate the expression pattern of the RRas2 gene in vivo. 
These animals, which were generated by the insertion of a 
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RRas2 in the heart and lung (Figures 1 and 
2), we could not see any major defect in the 
size, histological structure, and physiologi-
cal function of those two organs in 3-mo-old 
RRas2−/− mice (Supplemental Figure S1A 
and unpublished data). The male and fe-
male reproductive systems were also func-
tioning properly in the absence of R-Ras2/
TC21, as assessed by the normal size of the 
litters obtained in crosses between male 
and female RRas2−/− mice (Supplemental 
Table S1). Despite the high levels of expres-
sion previously detected for the RRas2 gene 
in white adipocytes (Figure 2), we did not 
find any alteration in the number, size, or fat 
content of these cells in RRas2−/− mice (Sup-
plemental Figure S1B). Similarly, we did not 
detect any alterations in the structure of ar-
terial vessels (unpublished data), blood 
pressure levels (Supplemental Table S2), or 
heart rates (Supplemental Table S2) be-
tween RRas2−/− and control mice. We did 
not find any obvious sign of cardiovascular 
remodeling, pulmonary hypertension, heart 
fibrosis, or renal fibrosis in RRas2−/− mice 
(unpublished data). Although the physiolog-
ical status of other organs was not closely 
monitored, the analysis of X-gal–stained tis-
sue sections indicated that the gross histol-
ogy of the heart, aorta, lung, intestine, blad-
der, white adipose tissue, mammary gland, 
kidney, testes, and ovaries was similar in 
RRas2−/− and RRas2+/− mice (unpublished 
data), thus suggesting that the lack of 
R-Ras2/TC21 expression does not induce 
major histological and/or developmental 
alterations in the tissues surveyed. Consis-
tent with all those data, RRas2−/− mice 
showed normal growth curves (Supplemen-
tal Figure S1C) and did not show enhanced 
mortality rates when compared with wild-
type counterparts, at least up to 1 yr of age 
(unpublished data).
R-Ras2/TC21 is necessary for proper 
mammary gland development
Unlike the case of other tissues, the full de-
velopment of the mammary gland is not 
fully achieved until the adult period. The 
first postnatal morphogenetic wave of this 
organ takes place at puberty. At this stage, 
the distal ends of ducts start proliferating 
and form multilayered terminal end buds (TEBs). These TEBs, which 
are composed of an external layer of cap cells and several layers of 
luminal epithelial cells, undergo serial cycles of proliferation, elon-
gation, bifurcation, and lateral branching to generate the highly ar-
borized structure typical of the mature mammary gland. These final 
tubules are composed of two cell layers: an outer one formed exclu-
sively by smooth muscle cell actin–positive myoepithelial cells, and 
a luminal one containing epithelial cells. A second wave of morpho-
genic activity occurs during pregnancy, in which luminal epithelial 
cells proliferate extensively and differentiate into milk-secreting 
bladder (Figure 2K). Confirming that the X-gal staining obtained 
in RRas2+/− and RRas2−/− mice was specific, we detected no X-gal 
signals in tissue sections obtained from RRas2+/+ mice (unpub-
lished data).
R-Ras2/TC21 is dispensable for the proper development 
and function of mouse organs
The wide expression pattern of the RRas2 gene raised the possibility 
that its encoded GTPase could exert critical functions in nonhe-
matopoietic tissues. Despite the high expression levels found for 
FIGURE 1: RRas2 gene expression during mouse embryonic development. (A–F) Whole-mount 
X-gal staining of E10.5 (A, B), E11.5 (C, D), and E13.5 (E, F) RRas2+/− embryos to reveal the 
expression (blue) of the RRas2 gene. The heart (A–D, F), interdigital area (F), and spinal cord (E) 
are indicated by filled arrowheads, black arrows, and open arrowheads, respectively. Scale bars, 
1 mm. (G, H) Sagittal sections of X-gal–stained E14.5 (G) and E16.5 (H) RRas2−/− embryos. Scale 
bars, 1 mm. In C–E, the signal seen in the head area is due to nonspecific diffusion of the X-gal 
staining. In G, the closed and open arrowheads signal the heart ventricle and atrium, 
respectively. In H, the closed and open arrowheads indicate the heart ventricle and intestine, 
respectively. The black and white arrowheads signal the thymus and lung, respectively. (I–L) 
Magnifications of heart (I), thymus (J), lungs (K), and intestine (L) areas present in X-gal/
eosin–stained E16.5 RRas2+/− embryos. Scale bar, 50 μm. (M, N) Images of thoracic (with [M, 
inset] or without thymus [M, main panel]) and abdominal (N) regions of an E16.5 RRas2−/− 
embryo stained with X-gal in toto. a, aorta; b, bladder; i, intestine; l, liver; la, left atrium; lu, lung; 
lv, left ventricle; pa, pulmonary artery; ra, right atrium; rv, right ventricle; t, thymus. Scale bar, 
500 μm.
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old (puberty), and 12-wk-old (postpubertal 
period) RRas2+/+ and RRas2−/− female mice. 
To that end, we extracted the mammary fat 
pads from animals of the indicated geno-
types, stained them with red carmine to visu-
alize the mammary gland tubules and TEBs, 
and then quantified the total gland area, the 
maximal length of extension of the tubules 
within the mammary fat pad, and the num-
ber of TEBs and branching points exhibited 
by the mammary glands under analysis. We 
found no major differences in any of those 
parameters in the mammary glands of 4-wk-
old R-Ras2/TC21-deficient and control mice 
(Figure 3, B, C, E, and F). However, when 
we analyzed 5-wk-old mice, we observed 
that the mammary glands extracted from 
RRas2−/− mice were significantly smaller than 
those obtained from control animals (Figure 
3, B–D). Those glands also displayed signifi-
cant lower numbers of TEBs (Figure 3, B and 
E) and branching points (Figure 3, B and F). 
Most of those differences disappeared in 
the mammary glands of 12-wk-old mice 
(Figure 3, B–D). However, unlike the case of 
control mice, we found that ∼50% of the 
mammary glands obtained from RRas2−/− 
mice still contained a significant number of 
TEBs (Figure 3E), further suggesting that the 
R-Ras2/TC21 deficiency induces a delay in 
the development of this gland. This pheno-
type was highly penetrant, since it was ob-
served in mice of homogenized (C57BL/6J, 
Figure 3) and mixed (129Sv/J × C57BL/6J, 
Supplemental Figure S2) genetic back-
grounds. In the latter strain, kinetics experi-
ments demonstrated that the developmen-
tal delay is present in both 5- and 6-wk-old 
RRas2−/− mice (Supplemental Figure S2). 
This maturational delay is circumscribed to 
the pubertal morphogenetic phase, be-
cause we could not detect any significant 
defect in the alveolar expansion of the 
mammary epithelium in lactating RRas2−/− 
mice (Supplemental Figure S3, A and B). 
The glands were also fully functional during 
lactation, as determined by the wild type–
like ratios of overall survival (Supplemental 
Figure S3C) and net weight gain (Supple-
mental Figure S3D) of the offspring of 
RRas2−/− mothers. Taken together, these 
results indicate that R-Ras2/TC21 is involved in the proper devel-
opmental kinetics of the mammary gland during the pubertal 
period.
Because the morphogenic activity of the mammary gland during 
puberty is triggered by estrogens produced by the ovary (Sternlicht 
et al., 2006), an organ that displays high levels of expression of 
the RRas2 gene (Figure 2), we were concerned with the possibility 
that the developmental defect found in the mammary glands of 
RRas2−/− mice could be a reflection of impaired estrogen production 
or other extrinsic programs. To address this possibility, we took advan-
tage of the known ability of isolated primary epithelial cells (MECs) to 
alveoli. Finally, after the lactation period, the mammary gland re-
gresses back to the former structure and size by the engagement of 
a large apoptotic program that wipes out ∼80% of the cells gener-
ated during pregnancy (Gjorevski and Nelson, 2011). Because 
of this, we decided to analyze in more detail the potential role of 
R-Ras2/TC21 in this organ. Consistent with a potential role in this 
process, we found that the expression of the RRas2 mRNA, although 
present in all stages of the mammary gland, became specifically up-
regulated during those two highly morphogenetic periods of the 
mammary gland (Figure 3A). Next we compared the structure of the 
mammary glands present in 4-wk-old (beginning of puberty), 5-wk-
FIGURE 2: Expression of the RRas2 gene in tissues of adult mice. (A) qRT-PCR analysis using 
total RNA from the indicated tissues (bottom) of a 3-mo-old RRas2+/+ mouse. BAT, brown 
adipose tissue; BG, bulbourethral gland; SSM, striated skeletal muscle; WAT, white adipose 
tissue. Expression values are given relative to levels found for the RRas2 transcript in the 
mammary gland (which were given an arbitrary value of 1). All values were normalized taking 
into consideration the expression levels of the housekeeping Gapdh mRNA in each sample. a.u., 
arbitrary units. (B–K) Cryostat sections obtained from the lung (B, C), testicle (D), ovarian corpus 
luteum (E), white adipose tissue (F), heart (G), aorta (H), mammary gland (I), duodenum (J), and 
bladder (K) of a 3-mo-old RRas2+/− mice were subjected to X-gal staining (blue) and 
counterstained with eosin (purple). In B and C, the closed arrowhead and asterisk signal the 
smooth muscle cells and alveolar cells, respectively. In C, open arrowheads indicate scattered 
X-gal–positive epithelial bronchial cells. In H, the closed arrowhead and asterisk signal vascular 
endothelial cells and smooth muscle cells, respectively. In I, the closed arrowhead indicates the 
outer ductal layer of myoepithelial cells. In J and K, the closed arrowheads and asterisks indicate 
the epithelial cells and muscle cell layer, respectively. Scale bars, 50 μm.
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regenerate a complete mammary gland tree upon implantation in the 
mammary fat pads of recipient animals. Using that property, we iso-
lated primary RRas2−/− MECs, transduced them in vitro with lentivi-
ruses encoding either no ectopic protein or a hemagglutinin (HA)-
tagged version of human R-RAS2/TC21 protein, and implanted them 
orthotopically in either RRas2+/+- or RRas2−/−-recipient female mice. 
The mammary glands of the recipient mice were surgically removed 
before the implantation step to allow the identification of the mam-
mary gland developed exclusively by the newly implanted cells. 
Seven weeks after implantation, we evaluated both the structure and 
extension of the mammary gland trees developed under each of 
those experimental conditions. These experiments revealed that 
mock-transfected RRas2−/− MECs generated smaller glands regard-
less of the genotype of the recipient mice used (Figure 4, A and B). 
We also observed that the expression of HA-RAS2/TC21 in RRas2−/− 
MECs restored normal gland development upon implantation on ei-
ther wild-type or RRas2−/−-recipient mice (Figure 4, A–C), a result indi-
cating that R-Ras2/TC21 plays intrinsic signaling roles in MECs. 
Consistent with this view, we could not detect any defect in the devel-
opment of the mammary gland when mock-infected wild-type MECs 
were implanted into RRas2−/−-recipient female mice (Figure 4, A 
and B). Taken together, these results indicate that the physiological/
cellular environment present in RRas2−/− mice does not negatively 
affect the morphogenetic process of the mammary gland.
R-Ras2/TC21, H-Ras, and N-Ras act nonredundantly during 
pubertal mammary gland development
Given the high sequence and signaling similarity between Ras and 
R-Ras subfamily GTPases (Drivas et al., 1990; Colicelli, 2004), we 
next investigated whether R-Ras2/TC21 could be functionally re-
dundant to H-Ras and N-Ras in this functional setting. To this end, 
we compared the pubertal mammary gland development in con-
trol, single RRas2−/−-knockout, double HRas−/−;NRas−/−-knockout 
(Esteban et al., 2001), and triple RRas2−/−;HRas−/−;NRas−/−-knockout 
mice. To facilitate such comparison, all these mouse strains were 
homogenized in the C57BL/6J genetic background. As previously 
seen with RRas2−/− mice (Figure 3), the prepubertal mammary gland 
primordium developed normally regardless of the genotypes of the 
animals analyzed in terms of total gland area (Figure 5, A and B), 
number of TEBs (Figure 5, A and D), and branching points (Figure 5, 
A and E). During pubertal morphogenesis, we observed that the 
glands generated in double H-Ras;N-Ras–deficient mice had, simi-
lar to those found in RRas2−/− mice (Figures 3 and 5, A, D, and E), 
fewer TEBs (Figure 5, A and D) and branching points (Figure 5, A 
and E) than those developed in control animals. However, unlike the 
case of RRas2−/− mice (Figures 3 and 5, A–C), these defects did not 
result in a defective growth within the mammary fat pad (Figure 5, 
A–C). In fact, the mammary glands of those mice were larger than 
those from other mouse genotypes (Figure 5B). Although the rea-
son for this difference is unknown, we surmise that it could be due 
to the presence of larger fat pads in those animals because the 
double HRas−/−;NRas−/− mice are slightly fatter than the rest of mouse 
knockout and control strains used in these experiments (R.M.L. and 
X.R.B, unpublished observations). The triple RRas2;HRas;NRas gene 
deficiency recapitulated, but it did not aggravate, the defects seen 
in the mammary glands of R-Ras2/TC21–deficient mice (Figure 5), 
indicating that the three GTPases do not act redundantly or addi-
tively during gland development. All the defects found in the pu-
bertal mammary glands of double HRas−/−;NRas−/−-knockout and 
triple RRas2−/−;HRas−/−;NRas−/−-knockout mice were erased after pu-
berty (Figure 5). We found similar survival rates in the offspring of 
triple RRas2−/−;HRas−/−;NRas−/− and wild-type mothers (82.1 ± 6.1% 
FIGURE 3: R-Ras2/TC21 regulates the timely development of the 
pubertal mammary gland. (A) qRT-PCR analysis of total RNA 
obtained from mammary glands extracted from the indicated 
stages. Prepubertal, pubertal, and adult virgins correspond to 
samples obtained from 3-, 8-, and 14-wk-old RRas2+/+ female mice, 
respectively. Early and late pregnancy correspond to female mice 
within weeks 1 and 2½ of pregnancy, respectively. The early and 
late lactation samples were taken 1 and 2 wk after labor, 
respectively. The involution phase samples were taken 3.5 d after 
offspring weaning. Data are given relative to the expression levels 
obtained in virgin adult state (which was given an arbitrary value of 
1). All values were normalized taking into consideration the 
expression levels of the housekeeping Gapdh mRNA in each 
sample. *p ≤ 0.05; ***p ≤ 0.001 (n = 3). (B) Representative images of 
carmine alum–stained mammary fat pads obtained from female 
mice of the indicated ages (top) and genotypes (left). Scale bars, 
500 μm. One of the inguinal lymph nodes is indicated by a white 
asterisk. (C–F) Quantification of the total area (C), maximal length 
(D), number of TEBs (E), and branching points (F) of mammary 
glands obtained from animals of the indicated genotypes and ages. 
*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 when compared with values 
obtained in the appropriate wild-type control (n = 5–10 animals per 
genotype and developmental stage).
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niques in both RRas2+/− and RRas2−/− mice, 
we could not find any detectable expression 
of the RRas2 gene in the mammary epithe-
lial buds of E11.5–13.5 embryos (Figure 1, 
C–F), indicating that this GTPase is not ex-
pressed in the earliest developmental stages 
of the mammary gland. In the case of puber-
tal glands, we detected expression of RRas2 
in the myoepithelial cells but not in the lumi-
nal epithelial cells present in the mammary 
gland ducts (Figure 6A), an expression pat-
tern identical to that seen later in fully devel-
oped glands (Figure 2I). However, in this 
case, we also observed significant X-gal 
staining in both the cap and a small fraction 
of TEB body cells (Figure 6A). The expres-
sion of the RRas2 gene in epithelial cells was 
also demonstrated by qRT-PCR using total 
RNA extracted from isolated MECs (Figure 
6B). Immunoblot analysis of total cellular 
MEC lysates using R-Ras2/TC21–specific 
antibody also confirmed the presence of the 
protein in epithelial cells (Figure 6C). The 
specificity of the antibody to R-Ras2/TC21 
was demonstrated by the absence of signals 
in RRas2−/− MECs (Figure 6C). H-Ras and N-
Ras were also detected by qRT-PCR in MECs 
(Figure 6B). These results indicate that R-
Ras2/TC21 is expressed constitutively in the 
myoepithelial layer of postnatal mammary 
ducts and, in an inducible and developmen-
tal-specific manner, in cap and epithelial 
cells of TEBs.
R-Ras2/TC21 is important for the 
proliferation of mammary epithelial 
cells in vivo
TEBs are critical for mammary gland devel-
opment, since they contain stem cells, un-
dergo extensive proliferative rounds, and 
condition both the branching and migra-
tion of the gland tubules during the puber-
tal morphogenetic phase of the mammary 
gland. Those functions are regulated by intrinsic signaling routes 
and by extensive cross-talk established with adipocytes, fibro-
blasts, and hematopoietic cells present in the surrounding mam-
mary fat pad (Gjorevski and Nelson, 2011). Given this, we next 
compared the functional status of those structures in control and 
RRas2−/− mice. Using antibodies to smooth muscle actin and im-
munofluorescence techniques, we could not observe any defect in 
the overall structure of TEBs in the glands of R-Ras2/TC21–defi-
cient mice (Figure 7A). Using flow cytometry techniques, we also 
did not detect major changes in the populations of epithelial cells 
present in the mammary glands of RRas2−/− mice (Supplemental 
Figure S4). To analyze the branching morphogenesis process, we 
resorted to the use of mammary organotypic cultures in three-di-
mensional Matrigel gels. This technique allows the formation of 
mammary organoids in culture that adopt the typical bilayered cell 
structure of the mammary gland tubules and, in addition, enables 
the evaluation of the branching program when the cultures are 
stimulated with specific extracellular ligands such as FGF2 (fibro-
blast growth factor 2). As expected, organoids cultured in the 
[n = 250] vs. 85 ± 3.5% [n = 500], respectively), further indicating that 
the mammary glands are functional in the absence of these three 
Ras subfamily GTPases. These data further indicate that R-Ras2/
TC21 and Ras proteins are important for the kinetics but not for the 
overall developmental program of this gland during the pubertal 
phase.
R-Ras2/TC21 is expressed in both cap and epithelial cells 
of terminal end buds during pubertal development 
of the mammary gland
The effect of the RRas2 gene deficiency in mammary gland devel-
opment—a process basically regulated by epithelial cells (Gjorevski 
and Nelson, 2011)—was at odds with the specific expression of 
R-Ras2/TC21 seen in the myoepithelial cells of the gland tubules 
during the X-gal staining experiments performed with adult mice. 
This observation, coupled with the up-regulation of the RRas2 gene 
found in specific developmental stages of the gland (Figure 3A), led 
us to study the expression of this gene in more detail during the 
development of the mammary gland. Using X-gal staining tech-
FIGURE 4: The developmental defects of the mammary glands of R-Ras2/TC21–deficient mice 
are due to intrinsic signaling deficiencies in MECs. (A) Representative images of the mammary 
glands developed in recipient female mice of the indicated genotypes (left) upon orthotopic 
transplantation with primary mammary epithelial cells (top). Those included control (left) and 
RRas2−/− (middle) cells transduced before transplantation with a noncoding lentivirus (middle) 
and RRas2−/− cells transduced with a lentivirus encoding a HA-tagged version of human R-RAS2/
TC21 protein (right). At 7 wk after transplantation, mammary fat pads were isolated, stained 
with carmine alum, and photographed. Scale bar, 500 μm. (B) Quantification of the total area 
occupied by the mammary gland generated in the transplantation experiments described in A. 
*p ≤ 0.05; **p ≤ 0.01 (n = 5–8). (C) Total cellular extracts from the indicated cultures of mammary 
epithelial cells were analyzed by Western blot (WB) with antibodies to HA (top) to reveal the 
expression of the ectopic HA-R-RAS2/TC21 proteins. As a loading control, the same extracts 
were immunoblotted with antibodies to tubulin α (bottom).
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absence of that mitogen showed typical 
smooth, spherical shape regardless of the 
genotype of the animals from which they 
were isolated (Supplemental Figure S5A, 
left). In the presence of FGF2, these or-
ganoids generated from animals of both 
genotypes showed a similar budding of 
new ducts in culture (Supplemental Figure 
S5, A and B), indicating that the lack of 
expression of the R-Ras2/TC21 GTPase 
does not impair this biological process. In-
dependent of the FGF2 culturing condi-
tions, immunofluorescence experiments 
demonstrated that organoids generated 
from control and RRas2−/− mice showed 
the typical two layers of myoepithelial and 
epithelial cells (Supplemental Figure S5C). 
Transwell migration assays conducted with 
isolated primary MECs in either the pres-
ence or absence of collagen also indicated 
that the lack of R-Ras2/TC21 does not af-
fect the migration properties of primary 
MECs (Supplemental Figure S5, D and E).
Next we evaluated the proliferation of 
TEBs by staining tissue sections with anti-
bodies to the proliferative marker Ki67. 
These studies revealed a statistically signifi-
cant defect in the number of proliferating 
cells in RRas2−/− mice (Figure 7, B and C). By 
contrast, no major defects were seen in the 
number of proliferating cells present in the 
surrounding stroma (Figure 7C), indicating 
that the R-Ras2/TC21 deficiency only af-
fects the proliferation of epithelial cells 
present in TEBs. Finally, the use of terminal 
deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL) assays revealed similar 
apoptotic rates in the TEBs of both control 
and RRas2−/− mice (Figure 7, D and E). Taken 
together, these results indicate that R-Ras2/
TC21 is not critical for the structure and 
budding process of the mammary gland 
and the efficient migration and survival epi-
thelial cells. By contrast, this GTPase seems 
to be specifically involved in the prolifera-
tion of epithelial cells within the TEBs.
Given that R-Ras2/TC21 can induce 
the activation of the PI3-K/Akt (McFall 
et al., 2001; Rosario et al., 2001; Murphy 
et al., 2002; Rong et al., 2002; Delgado et al., 
2009) and Raf/MEK/Erk (Graham et al., 1994; 
Movilla et al., 1999; Rosario et al., 1999) 
routes, we next analyzed the status of both 
signaling routes in mammary glands sec-
tions, using immunohistochemical analysis 
with antibodies to phosphorylated Akt and 
Erk, respectively. Whereas no defects were 
seen in the number of phospho-Akt–positive 
cells in the RRas2−/− gland TEBs (Figure 7, 
F and G), we did find that those gland 
structures had reduced numbers of phos-
pho-Erk–positive cells when compared 
FIGURE 5: R-Ras2/TC21 acts nonredundantly and nonadditively with H- and N-Ras GTPases 
during pubertal mammary gland development. (A) Representative images of carmine alum–
stained mammary fat pads obtained from female mice of the indicated ages (top) and 
genotypes (left). Scale bars, 500 μm. (B–E) Quantification of the total area (B), maximal length 
(C), number of TEBs (D), and branching points (E) of mammary glands obtained from animals of 
the indicated genotypes and ages. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 when compared with 
values obtained in the appropriate wild-type control (n = 5–11 animals per genotype and 
developmental stage).
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blot analysis of total cellular lysates con-
firmed the expression of the HA-R-RAS2/
TC21 GTPase in the appropriate infections 
of RRas2−/− MECs (Figure 8H).
Finally, we verified the status of the Akt 
and Erk routes in cultured primary MECs. To 
this end, cells were starved and then stimu-
lated with growth factors known to affect 
mammary morphogenesis, such as FGF2, 
EGF (epidermal growth factor), insulin-like 
growth factor (IGF), and hepatocyte growth 
factor (HGF). At the indicated time points, 
cells were lysed and the levels of stimulation 
of both routes determined by immunoblot 
analysis of total cellular lysates with antibod-
ies to phospho-Akt and phospho-Erk1/2. 
These experiments showed no significant 
variations of phospho-Akt between wild-
type and RRas2−/− MECs in any of the stimu-
lation conditions tested (Supplemental Fig-
ure S6). In the case of phospho-Erk1/2, we 
observed no significant variations upon 
stimulation of MECs with either EGF (Sup-
plemental Figure S6A) or FGF2 (Supplemen-
tal Figure S6B). Mild although reproducible 
defects in activation of this serine/threonine 
kinase were observed when RRas2−/− MECs 
were stimulated with either IGF (Supple-
mental Figure S6C) or HGF (Supplemental 
Figure S6D).
DISCUSSION
Despite the important functions described 
for R-Ras proteins in vitro, the characteriza-
tion of their physiological and developmen-
tal roles is still in its infancy. This scenario is 
beginning to change due to the develop-
ment of animal models for RRas1, RRas2, and RRas3 genes. The 
analysis of these mice has shown that whereas R-Ras1 plays roles in 
hematopoietic stem cells (Shang et al., 2011), antigen-presenting 
dendritic cells (Singh et al., 2012), and vascular smooth muscle/
endothelial cells (Komatsu and Ruoslahti, 2005), R-Ras2/TC21 is 
important for the peripheral maintenance of mature lymphocytes 
(Delgado et al., 2009) and T-cell trogocytosis (Martinez-Martin et al., 
2011). By contrast, RRas3−/− mice display no overt phenotype during 
the embryonic or postnatal period despite the high expression lev-
els of this gene in the brain (Nunez Rodriguez et al., 2006). Given 
the widespread expression pattern of some of those genes, is un-
likely, however, that these functions will be the only ones disrupted 
in those knockout mice. Here we used the recently described strain 
of RRas2−/− mice to unveil new functions of R-Ras2/TC21 outside the 
lymphoid system. This study revealed that this GTPase plays addi-
tional roles in the development of the mammary gland during pu-
berty. In particular, we saw that the lack of R-Ras2/TC21 leads to 
reduced number of TEBs and ductal branches during the pubertal 
development of the mammary gland, which, in turn, induces a 
marked delay in the arborization and extension of the mammary 
gland tree within the fat pad. This role is transient and very specific, 
because the lack of this GTPase does not affect the development of 
mammary gland primordium during the embryonic period, the large 
expansion of the gland during pregnancy, or the physiological func-
tion of the fully developed gland during lactation.
with parallel sections obtained from control mice (Figure 7, H and I). 
As in the case of the detection of Ki67-labeled cells (Figure 7C), the 
defect in phospho-Erk–positive cells was circumscribed to the MECs 
present in TEBs (Figure 7I).
R-Ras2/TC21 is also important for the proliferation 
of mammary epithelial cells in vitro
To rule out the possibility that the reduced proliferation rates of 
RRas2−/− TEB epithelial cells in vivo was due to non–cell-autonomous 
effects, we evaluated the intrinsic proliferation of isolated RRas2−/− 
MECs in vitro. We found that RRas2−/− MECs proliferated at lower 
rates than wild-type counterparts in two-dimensional cultures using 
both standard cell counting (Figure 8A) and 5-bromodeoxyuridine 
(BrdU)-labeling (Figure 8, B and C) determinations. The analysis of 
colonies formed in three-dimensional cultures also indicated that the 
elimination of R-Ras2/TC21 resulted in reduced proliferation rates, 
leading to the formation of very small colonies (Figure 8, D–G). Com-
parative studies showed that the effect of the R-Ras2/TC21 deficiency 
on primary MEC proliferation in vitro was very similar to that induced 
by the culturing of those cells in mitogen-free media (Figure 8, D and 
E) or in growth media containing a MEK (PD98059) inhibitor (Figure 
8, F and G). Wild type–like proliferation rates were restored both in 
two-dimensional (Figure 8C) and three-dimensional (Figure 8, D and 
E) culture conditions upon the lentiviral-mediated expression of wild-
type, HA-tagged human R-RAS2/TC21 in RRas2−/− MECs. Immuno-
FIGURE 6: Expression of the RRas2 gene in pubertal mammary glands. (A) Mammary gland 
sections from 6-wk-old RRas2−/− female mice were stained with X-gal (blue) and antibodies to 
smooth muscle cell actin (brown) and counterstained with nuclear fast red (purple). Left, a 
representative image of a duct; middle and right, two TEBs in different orientations. Black 
arrows signal myoepithelial cells double positive for X-gal and smooth muscle cell actin. Closed 
arrowheads indicate cap cells double positive for X-gal and smooth muscle cell actin. Open 
arrowheads pinpoint single X-gal–positive body cells. Scale bar, 50 μm. (B) Expression of the 
indicated Ras family transcripts in primary mammary epithelial cells derived from the indicated 
genotypes. Values are given relative to the expression levels of each transcript found in 
wild-type mice (which was given an arbitrary value of 1). n = 1 experiment performed in 
triplicate. (C) Western blot analysis demonstrating the expression of the endogenous R-Ras2/
TC21 protein in primary mammary epithelial cells (top). As loading control, aliquots of the same 
extracts were subjected to immunoblot analysis using antibodies to tubulin α (bottom).
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The comparison of the mammary glands 
of pubertal control and RRas2−/− female 
mice indicates that the lack of this GTPase is 
associated to defective proliferation of TEB 
epithelial cells. By contrast, alterations in 
cell viability or cell migration can be ruled 
out. The lack of migration defects is in con-
trast with previous data indicating that con-
stitutively active version of R-Ras2/TC21 
enhances the motility of primary breast epi-
thelial cells (Keely et al., 1999), a result that 
confirms the idea that data from overex-
pression studies do not necessarily reflect 
the actual roles of GTPases in vivo. Although 
R-Ras2/TC21 is expressed in tissues (ovary) 
and cells (vascular endothelial cells, adipo-
cytes, and hematopoietic cells) that in-
fluence mammary gland morphogenesis 
through hormonal and local paracrine sig-
nals (Gjorevski and Nelson, 2011), we be-
lieve that the biological defects found in 
RRas2−/− mice are mainly due to cell autono-
mous problems in mammary epithelial cells. 
In agreement with this possibility, we 
showed using transplantation and rescue 
experiments that the hormonal and/or 
stromal environment present in RRas2−/− 
mice is not a key factor in the developmen-
tal defects found in the mammary glands of 
those mice. Furthermore, we also detected 
proliferative defects when purified RRas2−/− 
primary mammary epithelial cells were 
maintained in two- and three-dimensional 
culture conditions.
Regarding the potential signaling ele-
ments involved in this route, our results 
show that the Akt route is activated normally 
both in vivo and in vitro in the absence of 
R-Ras2/TC21, indicating that this pathway 
cannot be accountable for the phenotype 
found in RRas2−/− mice. By contrast, we did 
find severe defects in the activation status of 
the Erk route in vivo, a result consistent with 
the known role of this pathway in the prolif-
eration and ductal branching of the pubertal 
mammary gland (Gjorevski and Nelson, 
2011). However, this signaling defect is 
much milder and stimulus specific when us-
ing isolated mammary epithelial ex vivo, 
suggesting that it cannot explain single-
handedly the proliferative defects shown by 
RRas2−/− epithelial cells in cell culture. We 
do not know the reason for the different ac-
tivation levels of the Erk route between the 
in vivo and in vitro conditions. One possibil-
ity is that the stronger defects seen in the 
former case could be due to the fact that 
cells are exposed to limited amounts of ex-
tracellular stimuli than when stimulated in 
vitro. Alternatively, they may reflect the pres-
ence of signaling cross-talk initiated by 
RRas2−/− epithelial cells, which, in turn, could 
FIGURE 7: Reduced proliferation and Erk activation of epithelial cells in pubertal RRas2−/− 
mammary glands. (A) Mammary glands from 5-wk-old animals of the indicated genotypes (top) 
were sectioned, stained with antibodies to smooth muscle cell actin (SMA, red), incubated with 
4′,6′-diamidino-2-phenylindole (DAPI, blue), and analyzed by immunofluorescence microscopy. 
The images show a representative section of TEBs. Cap cells are indicated with open 
arrowheads. Scale bar, 100 μm. (B, C) Mammary glands from 5-wk-old animals of the indicated 
genotypes (top) were subjected to immunohistochemical analysis with antibodies to Ki67 and 
analyzed by standard light microscopy (B) to quantify the number of Ki67-positive cells present 
in both TEBs and the surrounding stroma (C). Scale bar, 100 μm. **p ≤ 0.01 compared with 
appropriate wild-type control (n = 6–8). (D, E) Mammary glands obtained as described were 
subjected to TUNEL assays and analyzed by immunofluorescence (D), and the number of 
apoptotic, TUNEL-positive cells present in TEBs quantified de visu (E). Scale bar, 100 μm. 
(F–I) Mammary glands obtained from mice of the indicated genotypes were immunostained with 
antibodies to either phosphorylated Akt (F) or phosphorylated Erk1/2 (H) to quantify the 
percentage of phospho-Akt–positive (G) and phospho-Erk1/2–positive (I) cells present in TEBs 
and adjacent stroma. p, phospho. Scale bars in G and H, 100 μm. In I, ***p ≤ 0.001 when 
compared with values obtained in wild-type mice (n = 5).
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lead to reduced levels of paracrine activa-
tion of epithelial cells by the stromal cells in 
vivo. For example, it is known that estrogens 
trigger the expression of Areg in mammary 
epithelial cells, leading to the subsequent 
activation of the EGF receptor in stromal 
cells and the final, stromal-dependent stim-
ulation of epithelial cells (Sternlicht et al., 
2005). This hypothesis, however, is not 
supported by the observation that similar 
numbers of phospho-Erk–positive stromal 
cells exist in RRas2−/− and control mice, at 
least in the areas adjacent to TEBs. Given 
that mammary gland morphogenesis is reg-
ulated by many other tyrosine kinase recep-
tors (i.e., Ron, ephrin family receptors; 
Gjorevski and Nelson, 2011), another possi-
bility is that R-Ras2/TC21 could be activated 
in vivo by mitogen/receptor pairs different 
from those tested by us in vitro. In any case, 
we do not consider non–cell-autonomous 
defects because, as noted, we found that 
wild-type epithelial cells could develop nor-
mal mammary glands when transplanted 
into RRas2−/−-recipient female mice. Whether 
other known effectors of R-Ras2/TC21 (i.e., 
the RalGDS/Ral route) or new downstream 
elements contribute to this process remains 
to be determined.
Consistent with the phenotype observed, 
we detected a developmentally regulated 
expression of the RRas2 gene in the cap and 
body cells of TEBs, the structures that drive 
the proliferation, branching, and extension 
of the ductal tree (Gjorevski and Nelson, 
2011). This differential regulation is not un-
heard off in the case of the R-Ras subfamily. 
Indeed, other reports showed that the ex-
pression of the RRas2 gene can change in 
different cell types during physiological 
and/or pathological conditions (Drivas et al., 
1990; Kozian and Augustin, 1997; Larkin 
et al., 2004; Zhu et al., 2005; Rokavec et al., 
2008). Similarly, the down-regulation of the 
RRas1 gene has been described in vascular 
smooth muscle cells during both neointima 
formation and tumor-induced neoangio-
genesis (Komatsu and Ruoslahti, 2005). 
Finally, the R-Ras3/M-Ras protein levels 
increase during neuronal development 
(Nunez Rodriguez et al., 2006). These data 
indicate that, unlike the case of Ras subfam-
ily GTPases, these proteins are probably 
FIGURE 8: Defective in vitro proliferation of RRas2−/− primary mammary epithelial cells. 
(A, B) Proliferation of primary mammary epithelial cells of the indicated genotypes using 
standard cell number (A) and BrdU incorporation (B) determination experiments. ***p ≤ 0.001 
when compared with values obtained in control cells (n = 3). O.D., optical density. (C) Primary 
mammary epithelial cells obtained from RRas2−/− mice were transduced with either an empty 
lentivirus (RRas2−/−) or a lentivirus encoding HA-R-RAS2/TC21 protein (RRas2−/− + RRAS2) and 
the proliferation determined using BrdU incorporation assays. As control, we determined in 
parallel the proliferation of mock-infected wild-type mammary epithelial cells (RRas2+/+). 
***p ≤ 0.001 when compared with values obtained in mock-transduced RRas2−/− cells (n = 3). 
(D, E) The indicated sets of mammary epithelial cells (top) were embedded into Matrigel and 
cultivated in either starvation medium (SM) or growth medium (GM) for 10 d. At each 
experimental time point, cultures were photographed (D) and the volume of the colonies 
formed determined (E) as indicated in Materials and Methods. In D, scale bar, 50 μm. 
In E, *p ≤ 0.05 and **p ≤ 0.01 when compared with mock-infected RRas2−/− cells (n = 3). 
(F, G) Mammary epithelial cells of the indicated genotypes (left) were maintained in Matrigel 
cultures containing starvation medium, (F, left), growth medium with DMSO carrier (F, middle), 
or growth medium supplemented with the PD98059 MEK inhibitor (F, right). After 10 d, the 
colonies formed were photographed (F) and their volumes determined (G). In F, scale bar, 
50 μm. In G, ***p ≤ 0.001 (n = 3). (H) Western 
blot analysis demonstrating the expression of 
the ectopic HA-RRAS2/TC21 protein in the 
appropriate experimental samples used in 
the foregoing experiments (top). As loading 
control, aliquots of the same extracts were 
subjected to immunoblot analysis with 
antibodies to tubulin α (bottom).
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Welfare committees of both the University of Salamanca and the 
Consejo Superior de Investigaciones Científicas. RRas2−/− mice have 
been described previously (Delgado et al., 2009). Mice were main-
tained in a mixed 129Sv/J × C57BL/6J background or backcrossed 
for 10 generations to obtain RRas2−/− animals in a stabilized C57BL/6J 
background. RRas2−/−;HRas−/−;NRas−/−-knockout mice (C57BL/6J ge-
netic background) were generated by crossing RRas2−/− mice with 
double HRas−/−;NRas−/−-knockout mice (Esteban et al., 2001).
To genotype the RRas2 and HRas alleles present in offspring ani-
mals, we submitted tail DNA to PCR analysis at 94°C for 5 min, fol-
lowed by 35 cycles of denaturation (94°C, 30 s), annealing (60°C, 
30 s), and extension (72°C, 50 s). In the case of NRas-knockout mice, 
the annealing cycles were performed at 55°C for 30 s each. Primers 
used to identify RRas2 alleles included 5´-TGAAACAGGATCATGT-
TGTGGAG-3′ (forward), 5′-CAG GAG GAG TCC AAG AAG AC-3′ 
(reverse), and 5′-ATA AAC CCT CTT GCA GTT GCA TC-3′ (reverse). 
These primers yielded diagnostic PCR bands of 267 base pairs (in 
the case of RRas2+/+ mice) and 128 base pairs (in the case of RRas2−/− 
mice). RRas2+/− mice yielded two bands of 267 and 128 base pairs. 
Primers used to identify HRas alleles included 5′-CTA CCG GTG 
GAT GTG GAA TGT GTG CGA-3′ (forward), 5′-ATA GTT GTA GGT 
TGC ACC CAC ATG CCG-3′ (reverse), and 5′-ACC TGC CAA TGA 
GAA GCA CAC TTA GCC-3′ (reverse). These primers generated di-
agnostic bands of 434 (in the case of HRas+/+ mice), 336 (in the case 
of HRas−/− mice), and 434 plus 336 base pairs (in the case of HRas+/− 
mice). Primers used to identify NRas alleles were 5′-CCA GGA TTC 
TTA CCG AAA GCA AGT GGT G-3′ (forward), 5′-CAG AGC AGA 
TTG TAC TGA GAG TGC ACC-3′ (reverse), and 5′-GAT GGC AAA 
TAC ACA GAG GAA CCC TTC G-3′ (reverse). Amplifications with 
those primers yielded diagnostic fragments of 185 (in the case 
of NRas+/+ mice), 315 (in the case of NRas−/− mice), and 185 plus 
315 base pairs (in the case of NRas+/− mice).
To analyze RRas2 expression during embryonic development, 
pregnant female mice were killed at the indicated days after obser-
vation of the postfecundation vaginal plug and embryos extracted. 
Staging of embryos was verified using the information contained in 
Theiler (1989).
Cell culture
For lentiviral production, 5 × 106 Lenti-X 293T cells (Clontech) were 
plated onto 10-cm plates and maintained for 24 h in DMEM (Invitro-
gen, Carlsbad, CA) supplemented with 10% tetracycline-free fetal 
calf serum (Clontech). Cells were transfected with 7 μg of pRL1 using 
the Lenti-X HTX Packaging System (Clontech) according to the man-
ufacturer’s instructions. After 48 h, viral supernatants were collected, 
cleared by low-speed centrifugation, and concentrated 50-fold us-
ing the Lenti-X Concentrator (Clontech). Viral pellets were then re-
suspended in MEC primary growth medium (DMEM:F12 media 
[Invitrogen] containing 10% fetal calf serum [Invitrogen], 5 μg/ml in-
sulin [Sigma-Aldrich, St. Louis, MO], 5 ng/ml EGF [Sigma-Aldrich], 
100 μg/ml streptomycin [Invitrogen], 100 U/ml penicillin [Invitrogen], 
and 50 μg/ml gentamicin [Invitrogen]) and titered using the Lenti-X 
qRT-PCR Titration Kit (Clontech) according to the manufacturer’s in-
structions. Viral particles were kept at –80°C until experimentally 
used.
Cultures of primary MECs were generated from 8- to 12-wk-old 
wild-type and RRas2−/− female mice (C57BL/6J background). 
Mammary glands number 3, 4 (without lymph node), and 5 were 
isolated, minced with a #22 scalpel for 3 min, and digested in 
collagenase buffer (DMEM:F12 supplemented with 5% fetal calf 
serum, 2 mg/ml Clostridium histolyticum collagenase [Sigma-
Aldrich], 100 μg/ml streptomycin, and 100 U/ml penicillin) for 1 h 
subjected to a dual regulation at the gene expression level and the 
standard GDP/GTP cycle.
It should be noted that the phenotype described here can be an 
underestimation of the actual role of R-Ras2/TC21 in this gland, since 
mammary epithelial cells also express R-Ras1 (unpublished data) and 
Ras subfamily proteins (this work). We started to assess this possibility 
by comparing the phenotypes of single RRas2−/−, double 
HRas−/−;NRas−/−, and triple RRas2−/−;HRas−/−;NRas−/− mice. Our results 
indicate that these proteins, although affecting mammary gland mor-
phogenesis during puberty, do not seem to act additively or syner-
gistically in this process. It would be interesting in the near future 
to carry out similar studies with RRas1−/−;RRas2−/− mice in order to 
see whether these two R-Ras subfamily proteins have redundant 
roles during mammary gland development.
Although the RRas2 gene is expressed in organs that are criti-
cal for both embryonic and postnatal viability, our study also indi-
cates that the lack of expression of this GTPase does not affect 
the overall viability, physiology, or reproduction of mice. Whether 
the triple RRas2−/−;HRas−/−;NRas−/−-knockout mice have aggra-
vated defects in the postnatal period awaits further examination. 
In any case, it is clear that, unlike the lethal effects of the com-
bined K-Ras, H-Ras, and N-Ras inactivation in the postnatal pe-
riod (Drosten et al., 2010), the combined elimination of H-Ras, 
N-Ras, and R-Ras2/TC21 does not negatively affect the long-term 
viability of the mice. As discussed in the case of the mammary 
gland phenotype, it is possible that this mild phenotype is due to 
redundancy issues with R-Ras1, R-Ras3/M-Ras, and/or K-Ras pro-
teins. For example, RRas1 and RRas2 genes are coexpressed 
in vascular smooth muscle cells, vascular endothelial cells, and 
hematopoietic cells. In addition, it is also possible that R-Ras2/
TC21 may be important for the function of some of the aforemen-
tioned tissues during pathological conditions rather than during 
the course of normal physiological responses. Hence, the role of 
R-Ras1 in vascular remodeling could be picked up only when 
neointima- and angiogenic-triggering experimental conditions 
were conducted on otherwise normal RRas1−/− mice (Komatsu 
and Ruoslahti, 2005). It is possible therefore that R-Ras2/TC21 
could also play roles during specific pathological conditions as-
sociated to tissues of high expression of this GTPase, such as 
obesity, metabolic syndrome, and hypertension/tumor–driven 
cardiovascular remodeling. The exploration of all those possibili-
ties using single- and compound-knockout mice will provide ad-




To generate the lentiviral vector encoding HA-tagged human RRAS2 
(pRL1), a cDNA fragment encoding wild-type R-RAS2/TC21 was am-
plified by PCR using the pcDNA3-HA-RRAS2 plasmid (Delgado 
et al., 2009) as template and the primers 5′-GGC GCG GAT CCA 
TGT ATC CTT ATG ACG TGC CTG ACT ATG CCA GCG CCG CGG 
CCG GCT GGC GG-3′ (forward, BamH1 and HA epitope sites un-
derlined and in bold font, respectively) and 5′-CCC CCC GGA TCC 
CTC GAG CTA GAA AAT GAC ACA ATG G-3′ (reverse, BamH1 site 
underlined). After digestion with BamH1, the RRAS2 cDNA frag-
ment was cloned into BamH1-linearized pLVX-IRES-Hyg lentiviral 
vector (Clontech, Mountain View, CA).
Animal strains and genotyping
Animal care and work protocols were approved and carried out 
according to the regulations set forth by the Animal Research and 
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(StepOnePlus Real-Time PCR System Cycler; Applied Biosystems, 
Foster City, CA). Primers used for mRNA quantitation included 5′-
GTG GAT GGC TTC TGA CTT TG-3′ (forward for mouse RRas2), 5′-
AAA CTT CAA TGG GGC TGT TG-3′ (reverse for mouse RRas2), 
5′-AGG GAG CAG ATC AAG CGG GTG AAA G-3′ (forward for 
mouse HRas), 5′-AGA CTC AAC AGT GCG AGC AGC CA-3′ (re-
verse for mouse HRas), 5′-TGA CGA TGG CAC TCA AGG TTG TAT 
GG G-3′ (forward for mouse NRas), and 5′-CCA GGG ATG TCA 
GAA CCA GGG CA-3′ (reverse for mouse NRas). For normalization, 
we used the expression levels obtained in the different PCR reac-
tions for the housekeeping Gapdh gene using primers 5′-TCG ACC 
ACC AAC TGC TTA GC-3′ (forward) and 5′-TCT TCT GGG TGG 
CAG TGA TG-3′ (reverse).
Hemodynamic studies
Blood pressure and heart rates were recorded in conscious mice 
with a volume–pressure recording noninvasive blood pressure moni-
toring system (CODA; Kent Scientific, Torrington, CT), as previously 
described (Sauzeau et al., 2006, 2007).
Analysis of mammary gland development
Mammary fat pads were extracted from animals of the indicated 
age, placed on dry, silanized glass slides, and fixed overnight in 
Carnoy’s fixative (1:3:6 parts of glacial acetic acid:chloroform:100% 
ethanol). Tissues were rehydrated through successive incubations 
with 70% ethanol, followed by distilled water, and stained with red 
carmine overnight. Mammary glands were analyzed with a stereo-
microscope (SMZ800; Nikon) and acquired with a digital camera 
(Digital Sight DS-Fi1; Nikon). The mammary gland area was ob-
tained by calculating the area occupied by a lane drawn around the 
gland, including the nipple. The mammary gland length was mea-
sured from the end of the longest duct to a reference median point 
located between the nipple and the adjacent lymph node. In both 
cases, the analyses were carried out using ImageJ software (National 
Institutes of Health, Bethesda, MD). The number of terminal end 
buds and branching points were counted using photomicrographs 
of the entire gland.
Transplantation experiments
Both naive and lentiviral-transduced MECs were injected into either 
3-wk-old wild-type or RRas2−/−-recipient female mice, exactly as de-
scribed (Deome et al., 1959; Daniel et al., 1968; Welm et al., 2008). 
When needed, cells transduced with empty and HA-RAS2/TC21–
encoding lentiviruses were injected in each experiment in the left 
and right inguinal mammary fat pads of the same recipient animal, 
respectively.
Immunohistochemical analysis of mammary glands
Tissues were dissected, fixed in 10%-buffered Formalin, embedded 
in paraffin, cut into either 3- or 5-μm-thick sections, and stained 
with hematoxylin/eosin. When appropriate, sections were sub-
jected to immunohistochemical analysis using a mouse monoclo-
nal antibody to Ki67 (clone MM1, dilution 1:100; Novocastra, New-
castle upon Tyne, United Kingdom), rabbit polyclonal antibodies 
to smooth muscle actin (dilution 1:200; Biocare Medical, Concord, 
CA), phospho-Erk (dilution 1:400; Cell Signaling Technology, 
Beverly, MA) or phospho-Akt (clone EP2109Y, dilution 1:100; 
Epitomics, Burlingame, CA). After an overnight incubation, tissue 
slides were rinsed with PBS, incubated 1 h at room temperature 
in a milk/PBS solution containing a sheep anti–mouse or a goat 
anti–rabbit immunoglobulin G (IgG)–horseradish peroxidase (GE 
Healthcare, Piscataway, NJ), rinsed with PBS, and developed with 
at 37°C under moderate shaking. Mammary organoids were sepa-
rated from fat and single cells (such as fibroblasts and red cells) by 
600 × g centrifugation steps lasting 10 min (one), 5 min (one), and 
2 s (four). After each centrifugation step, cell pellets were resus-
pended in DMEM:F12 medium. Purified organoids were then 
trypsinized (0.5 mg/ml trypsin and 0.2 mg/ml EDTA in saline solu-
tion [Invitrogen]) for 20 min at 37°C, washed with DMEM:F12, in-
cubated with DNAseI (4 U/ml in DMEM:F12 [Sigma-Aldrich]) for 3 
min at 25°C, and filtered through a 70-μm cell strainer (BD Falcon, 
BD Biosciences, San Jose, CA). Cells were cultured in MEC primary 
growth medium (DMEM:F12 media containing 10% fetal calf 
serum, 5 μg/ml insulin, 5 ng/ml EGF, 100 μg/ml streptomycin, 
100 U/ml penicillin, and 50 μg/ml gentamicin) from passage 0 to 
passage 2. For growth factor stimulation, MECs were incubated for 
4 h in starvation medium (MEC primary growth medium lacking 
mitogens and containing 0.5% fetal calf serum), and EGF (5 nM; 
Sigma-Aldrich), FGF2 (1 nM; Sigma-Aldrich), IGF (5 nM; Sigma-
Aldrich), or HGF (1 nM; Sigma-Aldrich) was added.
MECs were infected with lentivirus as described (Deome et al., 
1959; Daniel et al., 1968; Welm et al., 2008). Briefly, 2 × 106 cells 
were transferred into a well of 24-well ultralow attachment plates 
(Corning, Corning, NY) and transduced with 1 × 107 titer units of 
virus in a volume of 800 μl of primary growth medium for 16 h.
X-gal staining in whole embryos and tissue sections
For whole-mount β-galactosidase assays, embryos and adult tis-
sues were dissected, fixed in phosphate-buffered saline solution 
(PBS) containing 0.2% glutaraldehyde (Sigma-Aldrich), 5 mM eth-
ylene glycol tetraacetic acid (Sigma-Aldrich), and 2 mM MgCl2 
(Sigma-Aldrich) for 30 min at 25°C, and stained in PBS containing 
1 mg/ml X-gal (Sigma-Aldrich), 2 mM MgCl2, 0.02% Nonidet P-40 
(Sigma-Aldrich), 5 mM potassium ferricyanide (Sigma-Aldrich), and 
0.01% sodium deoxycholate (Sigma-Aldrich). Embryos were ana-
lyzed with a Nikon SMZ800 stereomicroscope and acquired with a 
Nikon Digital Sight DS-Fi1 camera (Nikon, Melville, NY). Alterna-
tively, embryos and adult tissues were postfixed in 10%-buffered 
Formalin (Leica Microsystems, Jena, Germany), paraffin embed-
ded, sectioned (2–3 μm in thickness), and counterstained with eo-
sin except when otherwise stated.
For the determination of β-galactosidase activity in sections, 
embryos and adult tissue samples were dissected, fixed for 30 min 
at 4°C in PBS containing 2% paraformaldehyde (Sigma-Aldrich), 
cryoprotected by stepwise immersions in 15–30% sucrose (Sigma-
Aldrich)–PBS solutions, embedded in Tissue-Tek OCT compound 
(Sakura, Alphen aan den Rijn, Netherlands), and stored frozen at 
−75°C. Tissue blocks were then cut into 10-μm-thick sections using 
a cryostat (HM 505 N; Microm International GmbH, Walldorf, 
Germany). Sections were air dried for 1 h, rinsed in PBS, postfixed 
for 10 min at 4°C in PBS containing 2% paraformaldehyde, washed 
with PBS, and stained for 14 h at 37°C with embryo-staining 
solution. Sections were washed in distilled water and counter-
stained with eosin unless otherwise specified (Nagi et al., 2003). 
Histological sections were analyzed with an Olympus BX51TF 
microscope and acquired with an Olympus DP70 camera (Olympus, 
Tokyo, Japan). Digital slides were obtained with the Mirax scan 
(Zeiss).
qRT-PCR
Total RNAs were extracted using the RNeasy Mini Kit (Qiagen, 
Valencia, CA), and expression levels of transcripts for the indicated 
Ras family GTPases were determined by qRT-PCR using the Quanti-
Tect SYBR Green RT-PCR kit (Qiagen) and qRT-PCR apparatus 
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antibody (1:5000 dilution) for 1 h at room temperature. Immunore-
acting bands were developed using a standard chemiluminescence 
method (ECL; GE Healthcare).
Determination of mammary epithelial cell populations 
by flow cytometry
Freshly isolated MECs from 8-wk-old female mice of the indicated 
genotypes were washed twice with ice-cold PBS, resuspended in 
PBS at a density of 1 × 106/ml, and incubated at 4°C with fluorescein 
isothiocyanate–conjugated rat IgG to CD24 (clone M1/69, dilution 
1:400; BD Biosciences), allophycocyanin-labeled Armenian hamster 
IgG to CD29 (clone HMb1-1, dilution 1:1000; eBioscience, San 
Diego, CA), and phycoerythrin-conjugated rat IgG to CD49f (clone 
GoH3, dilution 1:200; eBioscience). After 30 min, cells were washed 
twice with ice-cold PBS and subjected to flow cytometry analysis 
using the FACSCalibur system (BD Biosciences). Raw data were pro-
cessed using the Cell Quest and Paint-a-Gate software (both from 
BD Biosciences). Samples were gated on the basis of forward- and 
side-scatter. Information about the populations characterized with 
these markers can be found in previous publications (Sleeman et al., 
2006; Stingl et al., 2006).
Branching and immunofluorescence assays using 
mammary organoids
Organoids obtained as indicated were not trypsinized and, instead, 
were incubated in DMEM:F12 containing 1× insulin/transferrin/so-
dium selenite liquid media supplement (Sigma-Aldrich), 100 μg/ml 
streptomycin, and 100 U/ml penicillin with or without 2.5 nM FGF2 
(Sigma-Aldrich). After 4 d in culture, bright-field pictures of the colo-
nies formed were taken using a Zeiss Axiovert 135 inverted micro-
scope coupled to a digital camera (C2724-95; Hamamatsu). Alterna-
tively, organoids were processed for immunofluorescence analysis. 
To this end, organoids were equilibrated in PBS containing 25% su-
crose for 1 h, washed in PBS, and resuspended in ice-cold 1:1 
methanol:acetone. After an overnight fixation at −20°C in the latter 
solution, organoids were reequilibrated for 1 h in PBS containing 
25% sucrose, blocked for 1 h with 5% fetal bovine serum, and incu-
bated for 2 h with a mouse monoclonal antibody to smooth muscle 
actin (clone 1A4, dilution 1:200; Sigma-Aldrich). After staining of the 
F-actin cytoskeleton with rhodamine-labeled phalloidin (dilution 
1:200; Cytoskeleton, Denver, CO), organoids images were captured 
using a confocal microscopy (SP5 DMI-6000B microscope; Leica) 
and processed using LAS AF software (Leica).
Migration assays with primary mammary epithelial cells 
in vitro
For standard migration assays, we used the CytoSelect 24-Well Cell 
Migration Assay (Cell Biolabs, San Diego, CA) according to the 
manufacturer’s protocol. Briefly, 2 × 105 cells in starvation medium 
were plated onto the upper side of an 8-μm-pore polycarbonate 
membrane that was exposed to an underneath chamber filled with 
MEC primary growth medium. After culturing at 37°C for 24 h, the 
inserts were taken, stained with Lysis Buffer/CyQuant GR Solution 
(Cell Biolabs), and fluorescence measured with a 485/528-nm filter 
set using a Synergy 4 Microplate Reader (BioTek, Winooski, VT). For 
migration assays in collagen I, we used the collagen I–coated Cy-
toSelect 24-Well Cell Haptotaxis Assay (Cell Biolabs). To this end, 
2 × 105 cells in starvation medium were plated onto the upper side 
of an 8-μm-pore polycarbonate membrane coated on the under-
side with collagen I and cultured as described. Inserts were then 
stained using Cell Stain Solution (Cell Biolabs) and incubated with 
Extraction Solution (Cell Biolabs), and absorbance was measured at 
diaminobenzidine (Dako, Glostrup, Denmark). Positive cells in all 
of these analyses were scored de visu using an Olympus BX51TF 
microscope and acquired with an Olympus DP70 camera. Apop-
totic cells were detected using the TUNEL-based In Situ Cell 
Detection kit (Roche, Indianapolis, IN). To this end, sections were 
deparafinized, hydrated, digested with proteinase K (Dako) for 
30 min at 37°C, and subjected to the TUNEL reaction according to 
the manufacturer’s instructions. TUNEL-positive cells in all those 
analysis were scored de visu using a standard immunofluorescence 
microscope (CTR600; Leica).
Immunofluorescence analysis of mammary glands
The fourth right and left mammary glands were dissected from 
6-wk-old virgin or lactating female mice (1 d after parturition), 
fixed in 10%-buffered Formalin, embedded in paraffin, cut into 
either 3- or 5-μm-thick sections, and serially incubated with a mouse 
monoclonal antibody to smooth muscle actin (clone 1A4, dilution 
1:200; Sigma-Aldrich) and a rabbit polyclonal antibody to mucin 
(MUC1, dilution 1:50; Abcam, Cambridge, MA). After an overnight 
incubation, tissue slides were rinsed in PBS, incubated 1 h at room 
temperature in a milk/PBS solution containing either a Cy3-conju-
gated goat anti–mouse IgG or a Cy3-conjugated goat anti–rabbit 
IgG–horseradish peroxidase (each diluted 1:200; Jackson Immu-
noResearch Laboratories, West Grove, PA), washed with PBS, 
stained with 4′,6′-diamidino-2-phenylindole (Sigma-Aldrich), and 
mounted using Vectashield media (Vector Laboratories, Burl-
ingame, CA). Microscopic analysis was performed using a Leica 
DM 6000B fluorescence microscope and a Hamamatsu ORCA-ER 
C4742-80 camera (Hamamatsu, Hamamatsu, Japan).
Immunoblot analysis
Cells were washed with ice-cold PBS solution and scrapped in 
20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Nonidet-P40 (Sigma-
Aldrich), 0.5% sodium deoxycholate (Sigma-Aldrich), 1 mM 
β-glycerophosphate (Sigma-Aldrich), 1 mM Na3VO4 (Sigma-Aldrich), 
50 mM NaF (Sigma-Aldrich), and a protease inhibitor cocktail (Com-
plete; Roche) at 4°C. After transfer to an Eppendorf tube and exten-
sive vortexing, lysates were cleared by centrifugation at 10,000 rpm 
for 10 min at 4°C and supernatants diluted in 2× SDS–PAGE sample 
buffer. Protein samples were denatured by boiling in SDS–PAGE 
sample buffer, separated electrophoretically, and transferred 
onto nitrocellulose filters using the iBlot Dry Blotting System 
(Invitrogen; Castro-Castro et al., 2011). Membranes were blocked 
using 5% nonfat dry milk in TBS-T (25 mM Tris-HCl, pH 8.0, 
150 mM NaCl, 0.1% Tween-20) for 1 h and then incubated at 4°C 
with the appropriate primary antibodies diluted in blocking buf-
fer. Those included monoclonal antibodies to the HA epitope 
(clone 16B12, dilution 1:1000; Covance) and tubulin α (clone 
DM1A, dilution 1:1000; Calbiochem, La Jolla, CA), a home-made, 
affinity-purified rabbit polyclonal antibody raised against the 
R-Ras2/TC21 C-terminal region (residues 183–198) that recog-
nizes specifically R-Ras2/TC21 but not the related R-Ras1 protein 
or other Ras superfamily proteins (1234, dilution 1:1000), a goat 
polyclonal antibody to total Akt (C-20, dilution 1:1000; Santa 
Cruz Biotechnology, Santa Cruz, CA), and rabbit polyclonal anti-
bodies to phospho-Akt (phosphorylated residue S473; dilution 
1:1000; Cell Signaling Technology), phospho-Erk1/2 (phosphory-
lated residues T202 + Y204 and T185 + Y187 in Erk1 and Erk2, respec-
tively; dilution 1:1000; Cell Signaling Technology), and total 
Erk1/2 (dilution 1:1000; Cell Signaling Technology). After three 
washes with TBS-T, the membrane was incubated with horserad-
ish peroxidase–conjugated protein A or the appropriate secondary 
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